Efficacy and Safety of Letrozole in Improving Semen Parameters of Subfertile Men with Moderate-to-Severe Oligoasthenoteratozoospermia: A Placebo-controlled Randomised Trial
Background: Currently lack of consensus regarding the medical treatment of men with Oligoasthenoteratozoospermia (OATS). Letrozole is an aromatase inhibitor and may improve semen quality by stimulating hormone synthesis and spermatogenesis. There is lack of evidence on the efficacy and safety of let...
Saved in:
| Main Authors: | Pallavi Ullur, N. S. Kubera, Soliappappan Manikandan, Nivedita Nanda, Sujatha Venkatraman, Anusuya Ram |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Journal of Human Reproductive Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jhrs.jhrs_160_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cep78 knockout causes sterility and oligoasthenoteratozoospermia in male mice
by: Min Liu, et al.
Published: (2025-01-01) -
Comparative analysis of ICSI outcomes with testicular or secondary ejaculated sperm in men with oligoasthenoteratozoospermia
by: Marzieh Derakhshan, et al.
Published: (2025-03-01) -
A two sample Mendelian randomized study of the association of sex hormones and behavioral and clinical risk factors with macular hole
by: Zetong Nie, et al.
Published: (2025-03-01) -
Estrogen/androgen balance in men with hyperestrogenism normalized by using letrozole of the aromatase inhibitor drug class
by: Z. Sh. Pavlova, et al.
Published: (2022-03-01) -
Letrozole and palbociclib in advanced breast cancer: Outcome from cancer institute, Chennai
by: Vijay Gnanaguru, et al.
Published: (2020-01-01)